sr 33557 has been researched along with verapamil in 11 studies
| Studies (sr 33557) | Trials (sr 33557) | Recent Studies (post-2010) (sr 33557) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
|---|---|---|---|---|---|
| 50 | 3 | 1 | 17,621 | 1,527 | 2,067 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (90.91) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatelain, P; Clinet, M; Gubin, J; Lucchetti, J; Mahaux, J; Nisato, D; Polster, P; Rosseels, G | 1 |
| Clinet, M; de Vogelaer, H; Gubin, J; Houben, C; Inion, H; Lucchetti, J; Mahaux, J; Peiren, M; Polster, P; Rosseels, G | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Attal, M; Bordier, C; Chatelain, P; Chiron, M; Jaffrézou, JP; Laurent, G; Levade, T; Thurneyssen, O | 1 |
| Chatelain, P; Gau, MN; Herbert, JM; Jaffrézou, JP; Laurent, G; Levade, T | 1 |
| Beaufort, P; Chatelain, P; Clinet, M; Laruel, R; Meysmans, L; Nokin, P | 1 |
| Chatelain, P; Christophe, B; Clinet, M; Manning, AS; Polster, P | 1 |
| Chatelain, P; Feys, G; Laruel, A; Manning, AS; Mouton, J | 1 |
| Berridge, G; Callaghan, R; Higgins, CF; Martin, C | 1 |
| Adovelande, J; Delèze, J; Schrével, J | 1 |
| Dol-Gleizes, F; Dongay, B; Herbert, JM | 1 |
11 other study(ies) available for sr 33557 and verapamil
| Article | Year |
|---|---|
A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
Topics: Animals; Binding Sites; Brain; Calcium Channel Blockers; Guinea Pigs; Indolizines; Male; Phenethylamines; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1992 |
Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
Topics: Animals; Calcium Channel Blockers; Cerebral Cortex; Guinea Pigs; Heterocyclic Compounds; Indolizines; Male; Muscle, Smooth, Vascular; Phenethylamines; Rats; Rats, Wistar; Structure-Activity Relationship | 1993 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunotoxins; Indolizines; Lipidoses; Lymphoma, T-Cell; Monensin; Perhexiline; Phenethylamines; Ricin; Tumor Cells, Cultured; Verapamil | 1992 |
Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein.
Topics: Animals; Calcium Channel Blockers; Drug Resistance; Indolizines; Leukemia, Experimental; Mice; Phenethylamines; Protein Kinase C; Second Messenger Systems; Sphingosine; Structure-Activity Relationship; Tumor Cells, Cultured; Verapamil | 1991 |
SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Topics: Animals; Binding Sites; Calcium; Calcium Channel Blockers; Diltiazem; In Vitro Techniques; Indolizines; Isradipine; Male; Myocardium; Oxadiazoles; Phenethylamines; Radioligand Assay; Rats; Rats, Inbred Strains; Sarcolemma; Verapamil | 1990 |
In vitro characterization of a novel Ca2+ entry blocker: SR 33805.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Diltiazem; Heart Rate; In Vitro Techniques; Indoles; Indolizines; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Phenethylamines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Sarcolemma; Sulfones; Verapamil | 1993 |
Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
Topics: Animals; Aorta, Thoracic; Calcinosis; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Cholecalciferol; Dose-Response Relationship, Drug; Indoles; Indolizines; Male; Mesenteric Arteries; Myocardium; Phenethylamines; Rats; Rats, Sprague-Dawley; Staining and Labeling; Sulfones; Verapamil | 1995 |
The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction.
Topics: Adenosine Triphosphatases; Allosteric Regulation; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; CHO Cells; Cricetinae; Enzyme Activation; Indolizines; Phenethylamines; Tritium; Verapamil; Vinblastine | 1997 |
Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Humans; Indolizines; Malaria, Falciparum; Phenethylamines; Plasmodium falciparum; Verapamil | 1998 |
Effect of fantofarone, a new Ca2+ channel antagonist, on angioplasty-induced vasospasm in an atherosclerotic rabbit model.
Topics: Angioplasty; Animals; Arteriosclerosis; Calcium Channel Blockers; Femoral Artery; Indolizines; Male; Phenethylamines; Rabbits; Vasodilator Agents; Verapamil | 1998 |